skip to Main Content
Recent News

 

Stay up to date on the latest news about Abpro, including press releases and upcoming publications.

 

Press Releases

NOV 16, 2020
Abpro Announces Peer-Reviewed Publication Demonstrating Efficacy of its Neutralizing Antibody Therapeutic Against COVID-19
Read More →
OCT 20, 2020
Abpro Announces Completion of Dosing in Phase 1 Study of its Neutralizing Antibody Therapeutic, ABP 300 for Treatment of COVID-19
Read More →
MAR 3, 2020
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
Read More →
FEB 28, 2019
Abpro and NJCTTQ Enter Into Partnership For Development of Multiple Novel Bispecific Antibodies
Read More →
NOV 29, 2016
Medimmune and Abpro Enter into A Collaborative Agreement For a Novel Bispecific Antibody
Read More →
OCT 13, 2016
GEN Roundup: Immunoassays: Life Science Critical Tools
Read More →
MAY 20, 2016
Abpro Announces Agreements with Two Boston Hospitals
Read More →
APR 25, 2016
Abpro Announces Investment and Partnership with Essex Bio
Read More →
OCT 10, 2014
Abpro Co-Founder Eugene Chan Wins Nokia Sensing XChallenge
Read More →

Publications

November 6, 2019
Abpro's TetraBi Platform for T-cell Engaging Antibodies targeting Claudin 18.2-expressing cancers Published for the 2019 SITC meeting
Read More →
MAY 16, 2019
Abpro's TetraBi Platform for T-cell Engaging Antibodies Published for the 2019 ASCO Meeting
Read More →
Back To Top